CDIO
Price
$1.01
Change
-$0.02 (-1.94%)
Updated
Dec 24 closing price
RVPH
Price
$1.78
Change
+$0.14 (+8.54%)
Updated
Dec 24 closing price
89 days until earnings call
Ad is loading...

CDIO vs RVPH

Header iconCDIO vs RVPH Comparison
Open Charts CDIO vs RVPHBanner chart's image
Cardio Diagnostics Holdings
Price$1.01
Change-$0.02 (-1.94%)
Volume$1.35M
CapitalizationN/A
Reviva Pharmaceuticals Holdings
Price$1.78
Change+$0.14 (+8.54%)
Volume$4.27M
CapitalizationN/A
CDIO vs RVPH Comparison Chart
Loading...
CDIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDIO vs. RVPH commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDIO is a StrongBuy and RVPH is a Hold.

Ad is loading...
COMPARISON
Comparison
Dec 25, 2024
Stock price -- (CDIO: $1.01 vs. RVPH: $1.78)
Brand notoriety: CDIO and RVPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDIO: 16% vs. RVPH: 165%
Market capitalization -- CDIO: $40.84M vs. RVPH: $82.91M
CDIO [@Biotechnology] is valued at $40.84M. RVPH’s [@Biotechnology] market capitalization is $82.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $385.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.4B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDIO’s FA Score shows that 0 FA rating(s) are green whileRVPH’s FA Score has 1 green FA rating(s).

  • CDIO’s FA Score: 0 green, 5 red.
  • RVPH’s FA Score: 1 green, 4 red.
According to our system of comparison, RVPH is a better buy in the long-term than CDIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDIO’s TA Score shows that 4 TA indicator(s) are bullish while RVPH’s TA Score has 5 bullish TA indicator(s).

  • CDIO’s TA Score: 4 bullish, 5 bearish.
  • RVPH’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, RVPH is a better buy in the short-term than CDIO.

Price Growth

CDIO (@Biotechnology) experienced а +18.82% price change this week, while RVPH (@Biotechnology) price change was +27.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.85%. For the same industry, the average monthly price growth was -1.81%, and the average quarterly price growth was +3.32%.

Reported Earning Dates

CDIO is expected to report earnings on Mar 31, 2023.

RVPH is expected to report earnings on Mar 24, 2025.

Industries' Descriptions

@Biotechnology (-0.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVPH($82.9M) has a higher market cap than CDIO($40.8M). CDIO YTD gains are higher at: -59.438 vs. RVPH (-65.437). CDIO has higher annual earnings (EBITDA): -7.89M vs. RVPH (-33.27M). RVPH has more cash in the bank: 5.56M vs. CDIO (1.98M). RVPH has less debt than CDIO: RVPH (83K) vs CDIO (720K). CDIO has higher revenues than RVPH: CDIO (35.7K) vs RVPH (0).
CDIORVPHCDIO / RVPH
Capitalization40.8M82.9M49%
EBITDA-7.89M-33.27M24%
Gain YTD-59.438-65.43791%
P/E RatioN/AN/A-
Revenue35.7K0-
Total Cash1.98M5.56M36%
Total Debt720K83K867%
FUNDAMENTALS RATINGS
RVPH: Fundamental Ratings
RVPH
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
12
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CDIORVPH
RSI
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
75%
MACD
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
41%
Bullish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
37%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 7 days ago
62%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
45%
Bearish Trend 2 days ago
72%
Aroon
ODDS (%)
Bullish Trend 2 days ago
24%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
CDIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRT9.800.23
+2.41%
Cross Timbers Royalty Trust
NAVI13.520.28
+2.11%
Navient Corp
COKE1206.6518.58
+1.56%
Coca-Cola Consolidated
UNH506.10-0.24
-0.05%
Unitedhealth Group
HONE12.13-0.01
-0.08%
HarborOne Bancorp

CDIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDIO has been loosely correlated with KRRO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if CDIO jumps, then KRRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDIO
1D Price
Change %
CDIO100%
-1.94%
KRRO - CDIO
35%
Loosely correlated
+0.02%
CMRX - CDIO
28%
Poorly correlated
+10.60%
INZY - CDIO
27%
Poorly correlated
-2.66%
TARA - CDIO
27%
Poorly correlated
+0.39%
UBX - CDIO
27%
Poorly correlated
+0.03%
More

RVPH and

Correlation & Price change

A.I.dvisor tells us that RVPH and GYRE have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RVPH and GYRE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVPH
1D Price
Change %
RVPH100%
+8.54%
GYRE - RVPH
30%
Poorly correlated
-2.46%
TNYA - RVPH
29%
Poorly correlated
+4.40%
INM - RVPH
26%
Poorly correlated
-0.43%
VACBF - RVPH
24%
Poorly correlated
N/A
CDIO - RVPH
24%
Poorly correlated
-1.94%
More